Ann: TGA registration of SARS-CoV-2 detection kit, page-93

Was brief discussion additionally regarding the fact that covid-19 no matter how awful it sounds has been a bonus as it will provide the business with additional funding and has opened up pathways to advertise the product where it may not have been necessarily used previously. Current quarter almost over and current testing levels should continue for another 6 months as a minimum which allows for 4 quarters (including previous) of net profits of around $20-25 million and potentially more plus monies already in the bank which suggests a very healthy financial position to be in.
Did ask the question regarding approvals and belive they are in the line waiting yet with covid 19 vaccinations/ treatments/ medications etc taking precedence in most countries, may take longer than expected, yet realistically all comes down to regulatory bodies timeframes and realistically wouldn’t expect to hear an answer (have to ask).
For me personally, a comforting discussion, and during covid-19, a company far better positioned than others to benefit during, and afterwards. I’m looking forward to the next quarterly as could give a really good indication of growth in Europe and new clients in US. Said I wouldnt buy more, and that still hasn’t changed as like balance in my portfolio rather than being too top heavy with one company, yet don’t think one could go wrong here at these prices longterm. All imo of course